4d Molecular Therapeutics Stock Probability of Future Stock Price Finishing Under 7.79
| FDMT Stock | USD 7.79 0.20 2.50% |
FDMT |
4D Molecular Target Price Odds to finish below 7.79
The tendency of FDMT Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move below current price in 90 days |
| 7.79 | 90 days | 7.79 | about 16.36 |
Based on a normal probability distribution, the odds of 4D Molecular to move below current price in 90 days from now is about 16.36 (This 4D Molecular Therapeutics probability density function shows the probability of FDMT Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days 4D Molecular Therapeutics has a beta of -0.48. This usually indicates as returns on the benchmark increase, returns on holding 4D Molecular are expected to decrease at a much lower rate. During a bear market, however, 4D Molecular Therapeutics is likely to outperform the market. Additionally 4D Molecular Therapeutics has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. 4D Molecular Price Density |
| Price |
Predictive Modules for 4D Molecular
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as 4D Molecular Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.4D Molecular Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. 4D Molecular is not an exception. The market had few large corrections towards the 4D Molecular's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold 4D Molecular Therapeutics, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of 4D Molecular within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.97 | |
β | Beta against Dow Jones | -0.48 | |
σ | Overall volatility | 3.13 | |
Ir | Information ratio | -0.28 |
4D Molecular Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of 4D Molecular for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for 4D Molecular Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| 4D Molecular generated a negative expected return over the last 90 days | |
| 4D Molecular has high historical volatility and very poor performance | |
| The company reported the previous year's revenue of 20.72 M. Net Loss for the year was (100.84 M) with loss before overhead, payroll, taxes, and interest of (77.12 M). | |
| 4D Molecular Therapeutics currently holds about 241.09 M in cash with (75.79 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 7.45. | |
| 4D Molecular has a poor financial position based on the latest SEC disclosures | |
| Over 96.0% of the company shares are owned by institutional investors |
4D Molecular Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of FDMT Stock often depends not only on the future outlook of the current and potential 4D Molecular's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. 4D Molecular's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 39.1 M | |
| Cash And Short Term Investments | 288.2 M |
4D Molecular Technical Analysis
4D Molecular's future price can be derived by breaking down and analyzing its technical indicators over time. FDMT Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of 4D Molecular Therapeutics. In general, you should focus on analyzing FDMT Stock price patterns and their correlations with different microeconomic environments and drivers.
4D Molecular Predictive Forecast Models
4D Molecular's time-series forecasting models is one of many 4D Molecular's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary 4D Molecular's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about 4D Molecular Therapeutics
Checking the ongoing alerts about 4D Molecular for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for 4D Molecular Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| 4D Molecular generated a negative expected return over the last 90 days | |
| 4D Molecular has high historical volatility and very poor performance | |
| The company reported the previous year's revenue of 20.72 M. Net Loss for the year was (100.84 M) with loss before overhead, payroll, taxes, and interest of (77.12 M). | |
| 4D Molecular Therapeutics currently holds about 241.09 M in cash with (75.79 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 7.45. | |
| 4D Molecular has a poor financial position based on the latest SEC disclosures | |
| Over 96.0% of the company shares are owned by institutional investors |
Additional Tools for FDMT Stock Analysis
When running 4D Molecular's price analysis, check to measure 4D Molecular's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy 4D Molecular is operating at the current time. Most of 4D Molecular's value examination focuses on studying past and present price action to predict the probability of 4D Molecular's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move 4D Molecular's price. Additionally, you may evaluate how the addition of 4D Molecular to your portfolios can decrease your overall portfolio volatility.